Solvaypharmaceuticals-us.comNews RoomMegan Bowman Named Vice President of Human Resources for Solvay Pharmaceuticals, Inc.
This Site All Sites

 


 


 
 
 

> April 14, 2008<
 
Megan Bowman Named Vice President of Human Resources for Solvay Pharmaceuticals, Inc.

 


Megan Bowman

MARIETTA, Ga. (April 14, 2008) - Solvay Pharmaceuticals, Inc. announced today that Megan Bowman has been named vice president of human resources.  In this role, Bowman will provide expert human resources guidance and oversee all human resources activity for the company in the U.S. Bowman will also serve as a member of the U.S. Pharmaceutical Leadership Team.

Prior to joining Solvay Pharmaceuticals, Bowman served as the senior vice president of human resources for MARSH, one of the world's largest insurance brokers. Previously, she was senior vice president of executive recruiting for Bank of America in Charlotte, North Carolina.  She brings more than 15 years of human resources experience to her role.

Bowman received a bachelor’s degree in psychology from Harvard University and a master’s in business in human resources and organizational management from Vanderbilt University.

About Solvay Pharmaceuticals, Inc.
Solvay Pharmaceuticals, Inc., of Marietta, Georgia is the U.S. subsidiary of Solvay Pharmaceuticals. For more information, visit www.solvaypharmaceuticals-us.com.

Solvay Pharmaceuticals is a research driven group of companies that constitute the global pharmaceutical business of the Solvay Group.  The company seeks to fulfill carefully selected, unmet medical needs in the therapeutic areas of neuroscience, cardio-metabolic, influenza vaccines, gastroenterology, and men’s and women’s health. Its 2007 sales were EUR 2.6 billion and it employs more than 9,000 people worldwide. For more information, visit www.solvaypharmaceuticals.com.
 
SOLVAY is an international chemical and pharmaceutical Group with headquarters in Brussels.  It employs more than 28,000 people in 50 countries.  In 2007, its consolidated sales amounted to EUR 9.6 billion, generated by its three sectors of activity:  Chemicals, Plastics and Pharmaceuticals.  Solvay (NYSE Euronext: SOLB.BE - Bloomberg: SOLB.BB - Reuters: SOLBt.BR) is listed on the NYSE Euronext stock exchange in Brussels. Details are available at www.solvay.com


| Email this |

 

 

 

 

 

accueil
© Solvay Pharmaceuticals, Inc. • Important information : Privacy Policy  -  Terms of Use • 
If you have any comments, please contact the webmaster
Date of last update: 6/26/2008